BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 31619219)

  • 1. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
    Wongsurakiat P; Chitwarakorn N
    BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.
    Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R
    BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care.
    Chalmers JD; Taylor JK; Mandal P; Choudhury G; Singanayagam A; Akram AR; Hill AT
    Clin Infect Dis; 2011 Sep; 53(6):503-11. PubMed ID: 21865188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
    Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H
    Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.
    Jenkins TC; Stella SA; Cervantes L; Knepper BC; Sabel AL; Price CS; Shockley L; Hanley ME; Mehler PS; Burman WJ
    Infection; 2013 Feb; 41(1):135-44. PubMed ID: 23160837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals.
    Davydov L; Ebert SC; Restino M; Gardner M; Bedenkop G; Uchida KM; Bertino JS
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):267-75. PubMed ID: 16466891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.
    Liapikou A; Ferrer M; Polverino E; Balasso V; Esperatti M; Piñer R; Mensa J; Luque N; Ewig S; Menendez R; Niederman MS; Torres A
    Clin Infect Dis; 2009 Feb; 48(4):377-85. PubMed ID: 19140759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
    Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
    Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
    Huijts SM; van Werkhoven CH; Boersma WG; Buijs J; Buunk G; Compaijen CJ; van Elde LJ; Gisolf JE; van der Kam R; Kluytmans JA; Kuipers BA; Mager JJ; Oppedijk B; Palmen F; Prins JM; van Reemst B; Silbermann MH; van Tiel FH; van der Wall E; van der Werf TS; Bonten MJ
    Neth J Med; 2013 Dec; 71(10):502-7. PubMed ID: 24394734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia.
    Kang SH; Jo YH; Lee JH; Jang DH; Kim YJ; Park I
    BMC Emerg Med; 2021 Sep; 21(1):108. PubMed ID: 34579649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pathway and Monthly Feedback Improve Adherence to Antibiotic Guideline Recommendations for Community-Acquired Pneumonia.
    Almatar M; Peterson GM; Thompson A; McKenzie D; Anderson T; Zaidi ST
    PLoS One; 2016; 11(7):e0159467. PubMed ID: 27454581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.
    Costantini E; Allara E; Patrucco F; Faggiano F; Hamid F; Balbo PE
    Intern Emerg Med; 2016 Oct; 11(7):929-40. PubMed ID: 27098057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.